Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, 100730, China.
Expert Rev Anticancer Ther. 2012 Feb;12(2):283-8. doi: 10.1586/era.11.197.
The involvement of microRNAs (miRs) in numerous pathological conditions is well established. In many kinds of cancer cells and animal models, various miRs have been shown to act as oncogenes or tumor suppressors. Recently, it was found that circulating miRs can be detected, and may be associated, with the clinicopathological features and prognosis of cancers, thus, providing potential novel diagnostic and prognostic markers for malignancies in humans. This review aims to address these issues based on recently published literature.
微 RNA(miRs)在许多病理条件中的参与已得到充分证实。在许多类型的癌细胞和动物模型中,各种 miRs 被证明可以作为癌基因或肿瘤抑制因子发挥作用。最近发现,循环 miRs 可以被检测到,并且可能与癌症的临床病理特征和预后相关,因此为人类恶性肿瘤提供了潜在的新型诊断和预后标志物。本综述旨在根据最近发表的文献讨论这些问题。